Bravecto PLUS Topical Solution for Cats 13.8 to 27.5 lbs (1 Tube)
Bravecto Plus is used for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment of infections with intestinal roundworm (Toxocara cati; 4th stage larvae, immature adults and adults) and hookworm (Ancylostoma tubaeforme; 4th stage larvae, immature adults and adults). Bravecto Plus kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Ixodes scapularis (black-legged tick) and Dermacentor variabilis (American dog tick)] for 2 months in cats and kittens 6 months of age and older and weighing 2.6 lb or greater.
How To Use
Bravecto Plus should be administered topically as a single dose every 2 months according to the Dosage Schedule below to provide a minimum dose of 18.2 mg/lb (40 mg/kg) fluralaner and 0.9 mg/lb (2 mg/kg) moxidectin.
|Body Weight Ranges (lbs)||Fluralaner Content (mg)/tube||Moxidectin content (mg/tube)||Tubes Administered|
|>6.2 – 13.8||250||12.5||One|
|>13.8 – 27.5*||500||25||One|
* Cats over 27.5 lb should be administered the appropriate combination of tubes
500 mg/tube Fluralaner and 25 mg/tube Moxidectin.
For topical use only. Avoid oral ingestion. Fluralaner, one of the ingredients in Bravecto Plus, is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. Use with caution in cats that are heartworm positive. Bravecto Plus has not been shown to be effective in kittens less than 6 months of age. The safety of Bravecto Plus has not been established in breeding, pregnant, and lactating cats. The effectiveness of Bravecto Plus to prevent heartworm disease after bathing or water immersion has not been evaluated.